Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently incurable form of brain ...

PrEP is one of the most powerful tools in HIV prevention. Yet for many Black LGBTQ+ people, getting access to the medication is far harder than it should be.

Human fetal tissue research has helped in the development of some vaccines.

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Still, he's not ready to declare the end of global progress. "As hard as last year was, I don't believe we will slide back ...

The National Institutes of Health (NIH) said that it will stop funding all research that uses human fetal tissue, ending ...